What are the major opportunities in the Bronchiolitis Obliterans Syndrome market? What are the strategies for the Bronchiolitis Obliterans Syndrome market?

For detailed insights on the major opportunities and strategies in the Bronchiolitis Obliterans Syndrome market, Read More

How does the Bronchiolitis Obliterans Syndrome market relate to the overall economy and other similar markets?

For detailed insights on Bronchiolitis Obliterans Syndrome's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Bronchiolitis Obliterans Syndrome market growth? SWOT analysis of the Bronchiolitis Obliterans Syndrome market.

For detailed insights on the key dynamics influencing the Bronchiolitis Obliterans Syndrome market growth and SWOT analysis of the Bronchiolitis Obliterans Syndrome industry, Read More

Global Bronchiolitis Obliterans Syndrome Market Report 2025

Item added to cart!

Report Price : $4490.00

Pages : 200

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Bronchiolitis Obliterans Syndrome Global Market Report 2025

Name: Bronchiolitis Obliterans Syndrome Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Treatment Type (Medication, Oxygen Therapy, Lung Transplant), By Diagnosis (Pulmonary Function Tests, Imaging Tests, Lung Biopsy, Other Diagnosis), By Disease Type (Acute Bronchiolitis, Chronic Bronchiolitis Obliterans Syndrome), By End-User (Hospitals, Specialty Clinics, Diagnostic Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Bronchiolitis Obliterans Syndrome Market?

Bronchiolitis obliterans syndrome (BOS) is a chronic and progressive lung disorder marked by inflammation and scarring that narrows the small airways. It often arises as a complication following lung or stem cell transplantation, indicating chronic graft rejection. Early detection of BOS is crucial for prompt treatment to slow its progression and help maintain lung function.

The main treatment types of bronchiolitis obliterans syndrome are medication, oxygen therapy, and lung transplant. Medication manages bronchiolitis obliterans syndrome (BOS) by controlling inflammation, slowing disease progression, and improving lung function. It is diagnosed with several diagnoses, such as pulmonary function tests, imaging tests, lung biopsy, and others for different disease types, including acute bronchiolitis and chronic bronchiolitis obliterans syndrome, and is used by various end users, such as hospitals, specialty clinics, diagnostic centers, and others.

Bronchiolitis Obliterans Syndrome Market Size and growth rate 2025 to 2029: Graph

What Is The Bronchiolitis Obliterans Syndrome Market Size 2025 And Growth Rate?

The bronchiolitis obliterans syndrome market size has grown strongly in recent years. It will grow from $1.46 billion in 2024 to $1.59 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing incidence of post-transplant complications, rising awareness among healthcare professionals, growing utilization of immunosuppressive therapies, increasing research focus on rare pulmonary disorders, and growing adoption of advanced diagnostic imaging and lung function tests.

What Is The Bronchiolitis Obliterans Syndrome Market Growth Forecast?

The bronchiolitis obliterans syndrome market size is expected to see strong growth in the next few years. It will grow to $2.23 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing lung transplant procedures globally, a rising pipeline of targeted BOS therapies, growing government and private funding for orphan diseases, increasing collaborations and licensing agreements, and rising demand for personalized medicine and biomarkers. Major trends in the forecast period include advancements in inhaled drug delivery systems, integration of artificial intelligence in pulmonary diagnostics, technology-driven development of precision medicine, developments in bioinformatics and clinical trial analytics, and advancements in immunomodulatory therapies.

Book your 30 minutes free consultation with our research experts

How Is The Bronchiolitis Obliterans Syndrome Market Segmented?

The bronchiolitis obliterans syndrome market covered in this report is segmented –

1) By Treatment Type: Medication, Oxygen Therapy, Lung Transplant

2) By Diagnosis: Pulmonary Function Tests, Imaging Tests, Lung Biopsy, Other Diagnosis

3) By Disease Type: Acute Bronchiolitis, Chronic Bronchiolitis Obliterans Syndrome

4) By End-User: Hospitals, Specialty Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Medication: immunosuppressants, Corticosteroids, Antibiotics, Bronchodilators, Anti-Inflammatory Agents

2) By Oxygen Therapy: Continuous Oxygen Therapy, Intermittent Oxygen Therapy, Portable Oxygen Therapy, Hyperbaric Oxygen Therapy

3) By Lung Transplant: Single Lung Transplant, Double Lung Transplant, Living Donor Lung Transplant, Retransplantation

What Is Driving The Bronchiolitis Obliterans Syndrome Market? The Growing Number Of Lung Transplantations Is Fueling The Growth Of The Market Due To The Rising Need To Treat Advanced Respiratory Conditions And Improve Patient Outcomes

The growing number of lung transplantations is expected to propel the growth of the bronchiolitis obliterans syndrome market going forward. Lung transplantation is a surgical operation where a damaged or malfunctioning lung is replaced with a healthy lung from a donor to improve breathing. Lung transplantations are increasing due to advancements in surgical techniques that have significantly improved the success rates and reduced complications, making the procedure safer and more accessible for patients in need. Lung transplantation can effectively treat advanced bronchiolitis obliterans syndrome by replacing damaged lungs with healthy donor lungs, improving breathing and lung function. For instance, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit scientific and educational organization, lung transplants had the largest proportional growth from 3,026 transplants in 2023 to 3,340 in 2024, an increase of 10.4 percent. Therefore, the growing number of lung transplants is driving the growth of the bronchiolitis obliterans syndrome market.

What Is Driving The Bronchiolitis Obliterans Syndrome Market? The Increasing Clinical Trials Are Fueling The Growth Of The Market Due To Their Role In Advancing Treatment Options And Enhancing Disease Understanding

The increasing clinical trials are expected to propel the growth of the bronchiolitis obliterans syndrome market going forward. Clinical trials refer to research studies conducted in humans to evaluate the safety, efficacy, and effectiveness of medical interventions such as drugs, medical devices, procedures, or behavioral therapies. Clinical trials are rising due to increasing demand for personalized medicine, requiring more studies to validate targeted, gene-based therapies. Clinical trials support bronchiolitis obliterans syndrome treatment by testing new therapies aimed at easing inflammation and preserving lung function. They also enhance understanding of disease progression and treatment safety. For instance, in November 2023, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, the total number of industry-sponsored clinical trials initiated annually in the UK saw a slight increase of 4.3%, rising from 394 in 2021 to 411 in 2022. Therefore, increasing clinical trials is driving the growth of the bronchiolitis obliterans syndrome market.

Who Are The Major Players In The Global Bronchiolitis Obliterans Syndrome Market?

Major companies operating in the bronchiolitis obliterans syndrome market are Pfizer Inc., Boehringer Ingelheim, University of California Health, Texas Children’s Hospital, Incyte Corporation, Apollo Hospitals, Mallinckrodt Pharmaceuticals plc, Zambon Company S.p.A., Fortis Healthcare, St. Louis Children's Hospital, Mayo Foundation for Medical Education and Research, Medicover Hospitals, Renovion Inc., Mereo BioPharma Group PLC, OrphAI Therapeutics, Koutif Therapeutics, ArkBio, Altavant Sciences, Breath Therapeutics, University of Alberta Hospital

What Are The Key Trends Of The Global Bronchiolitis Obliterans Syndrome Market? Advancements In At-Home Nebulized Therapies Accelerate Treatment For Bronchiolitis Obliterans Syndrome

Major companies operating in the bronchiolitis obliterans syndrome market are focusing on developing advanced solutions such as at-home nebulized therapy to enhance medication adherence and slow disease progression through targeted, continuous treatment. At-home nebulized therapy involves using a nebulizer to transform liquid medication into a breathable mist, allowing direct delivery to the lungs. This convenient, self-administered treatment enables effective management of respiratory conditions from the comfort of home. For instance, in March 2023, Renovion, Inc., a US-based clinical-stage pharmaceutical company, launched ARINA-1, which received Food and Drug Administration (FDA) Fast Track Designation for aiming at preventing the progression of bronchiolitis obliterans syndrome (BOS) in patients with bilateral lung transplants. This regulatory milestone underscores ARINA-1’s potential to address a critical unmet medical need in transplant medicine. The Fast Track status enables more frequent communication with the FDA and prioritizes ARINA-1 for accelerated development and review, reflecting Renovion's commitment to advancing respiratory health through innovative, patient-focused therapeutics.

Need data on a specific region in this market?

Request Regional Data

What Is The Regional Outlook For The Global Bronchiolitis Obliterans Syndrome Market?

North America was the largest region in the bronchiolitis obliterans syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bronchiolitis obliterans syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bronchiolitis obliterans syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Bronchiolitis Obliterans Syndrome Market?

The bronchiolitis obliterans syndrome market consists of revenues earned by entities providing services such as psychological counseling, patient monitoring and follow-up care, nutritional support, and pulmonary rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The bronchiolitis obliterans syndrome market also includes sales of high-resolution CT (HRCT) scanner, oxygen concentrators, flexible bronchoscope, and invasive ventilators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Bronchiolitis Obliterans Syndrome Industry?

The bronchiolitis obliterans syndrome market research report is one of a series of new reports from The Business Research Company that provides bronchiolitis obliterans syndrome market statistics, including the bronchiolitis obliterans syndrome industry global market size, regional shares, competitors with the bronchiolitis obliterans syndrome market share, detailed bronchiolitis obliterans syndrome market segments, market trends, opportunities, and any further data you may need to thrive in the bronchiolitis obliterans syndrome industry. This bronchiolitis obliterans syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Bronchiolitis Obliterans Syndrome Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.59 billion
Revenue Forecast In 2034	$2.23 billion
Growth Rate	CAGR of 8.9% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The bronchiolitis obliterans syndrome market covered in this report is segmented – 1) By Treatment Type: Medication, Oxygen Therapy, Lung Transplant 2) By Diagnosis: Pulmonary Function Tests, Imaging Tests, Lung Biopsy, Other Diagnosis 3) By Disease Type: Acute Bronchiolitis, Chronic Bronchiolitis Obliterans Syndrome 4) By End-User: Hospitals, Specialty Clinics, Diagnostic Centers, Other End-Users Subsegments: 1) By Medication: Immunosuppressants, Corticosteroids, Antibiotics, Bronchodilators, Anti-Inflammatory Agents 2) By Oxygen Therapy: Continuous Oxygen Therapy, Intermittent Oxygen Therapy, Portable Oxygen Therapy, Hyperbaric Oxygen Therapy 3) By Lung Transplant: Single Lung Transplant, Double Lung Transplant, Living Donor Lung Transplant, Retransplantation
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Boehringer Ingelheim, University of California Health, Texas Children’s Hospital, Incyte Corporation, Apollo Hospitals, Mallinckrodt Pharmaceuticals plc, Zambon Company S.p.A., Fortis Healthcare, St. Louis Children's Hospital, Mayo Foundation for Medical Education and Research, Medicover Hospitals, Renovion Inc., Mereo BioPharma Group PLC, OrphAI Therapeutics, Koutif Therapeutics, ArkBio, Altavant Sciences, Breath Therapeutics, University of Alberta Hospital
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Bronchiolitis Obliterans Syndrome Market Characteristics

3. Bronchiolitis Obliterans Syndrome Market Trends And Strategies

4. Bronchiolitis Obliterans Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bronchiolitis Obliterans Syndrome Growth Analysis And Strategic Analysis Framework

5.1. Global Bronchiolitis Obliterans Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Bronchiolitis Obliterans Syndrome Market Growth Rate Analysis

5.4. Global Bronchiolitis Obliterans Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Bronchiolitis Obliterans Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Bronchiolitis Obliterans Syndrome Total Addressable Market (TAM)

6. Bronchiolitis Obliterans Syndrome Market Segmentation

6.1. Global Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medication

Oxygen Therapy

Lung Transplant

6.2. Global Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pulmonary Function Tests

Imaging Tests

Lung Biopsy

Other Diagnosis

6.3. Global Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Bronchiolitis

Chronic Bronchiolitis Obliterans Syndrome

6.4. Global Bronchiolitis Obliterans Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Diagnostic Centers

Other End-Users

6.5. Global Bronchiolitis Obliterans Syndrome Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immunosuppressants

Corticosteroids

Antibiotics

Bronchodilators

Anti-Inflammatory Agents

6.6. Global Bronchiolitis Obliterans Syndrome Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Continuous Oxygen Therapy

Intermittent Oxygen Therapy

Portable Oxygen Therapy

Hyperbaric Oxygen Therapy

6.7. Global Bronchiolitis Obliterans Syndrome Market, Sub-Segmentation Of Lung Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single Lung Transplant

Double Lung Transplant

Living Donor Lung Transplant

Retransplantation

7. Bronchiolitis Obliterans Syndrome Market Regional And Country Analysis

7.1. Global Bronchiolitis Obliterans Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Bronchiolitis Obliterans Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bronchiolitis Obliterans Syndrome Market

8.1. Asia-Pacific Bronchiolitis Obliterans Syndrome Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bronchiolitis Obliterans Syndrome Market

9.1. China Bronchiolitis Obliterans Syndrome Market Overview

9.2. China Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bronchiolitis Obliterans Syndrome Market

10.1. India Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bronchiolitis Obliterans Syndrome Market

11.1. Japan Bronchiolitis Obliterans Syndrome Market Overview

11.2. Japan Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bronchiolitis Obliterans Syndrome Market

12.1. Australia Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bronchiolitis Obliterans Syndrome Market

13.1. Indonesia Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bronchiolitis Obliterans Syndrome Market

14.1. South Korea Bronchiolitis Obliterans Syndrome Market Overview

14.2. South Korea Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bronchiolitis Obliterans Syndrome Market

15.1. Western Europe Bronchiolitis Obliterans Syndrome Market Overview

15.2. Western Europe Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bronchiolitis Obliterans Syndrome Market

16.1. UK Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bronchiolitis Obliterans Syndrome Market

17.1. Germany Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bronchiolitis Obliterans Syndrome Market

18.1. France Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bronchiolitis Obliterans Syndrome Market

19.1. Italy Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bronchiolitis Obliterans Syndrome Market

20.1. Spain Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bronchiolitis Obliterans Syndrome Market

21.1. Eastern Europe Bronchiolitis Obliterans Syndrome Market Overview

21.2. Eastern Europe Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bronchiolitis Obliterans Syndrome Market

22.1. Russia Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bronchiolitis Obliterans Syndrome Market

23.1. North America Bronchiolitis Obliterans Syndrome Market Overview

23.2. North America Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bronchiolitis Obliterans Syndrome Market

24.1. USA Bronchiolitis Obliterans Syndrome Market Overview

24.2. USA Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bronchiolitis Obliterans Syndrome Market

25.1. Canada Bronchiolitis Obliterans Syndrome Market Overview

25.2. Canada Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bronchiolitis Obliterans Syndrome Market

26.1. South America Bronchiolitis Obliterans Syndrome Market Overview

26.2. South America Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bronchiolitis Obliterans Syndrome Market

27.1. Brazil Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bronchiolitis Obliterans Syndrome Market

28.1. Middle East Bronchiolitis Obliterans Syndrome Market Overview

28.2. Middle East Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bronchiolitis Obliterans Syndrome Market

29.1. Africa Bronchiolitis Obliterans Syndrome Market Overview

29.2. Africa Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bronchiolitis Obliterans Syndrome Market Competitive Landscape And Company Profiles

30.1. Bronchiolitis Obliterans Syndrome Market Competitive Landscape

30.2. Bronchiolitis Obliterans Syndrome Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Boehringer Ingelheim Overview, Products and Services, Strategy and Financial Analysis

30.2.3. University of California Health Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Texas Children’s Hospital Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Incyte Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Bronchiolitis Obliterans Syndrome Market Other Major And Innovative Companies

31.1. Apollo Hospitals

31.2. Mallinckrodt Pharmaceuticals plc

31.3. Zambon Company S.p.A.

31.4. Fortis Healthcare

31.5. St. Louis Children's Hospital

31.6. Mayo Foundation for Medical Education and Research

31.7. Medicover Hospitals

31.8. Renovion Inc.

31.9. Mereo BioPharma Group PLC

31.10. OrphAI Therapeutics

31.11. Koutif Therapeutics

31.12. ArkBio

31.13. Altavant Sciences

31.14. Breath Therapeutics

31.15. University of Alberta Hospital

32. Global Bronchiolitis Obliterans Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bronchiolitis Obliterans Syndrome Market

34. Recent Developments In The Bronchiolitis Obliterans Syndrome Market

35. Bronchiolitis Obliterans Syndrome Market High Potential Countries, Segments and Strategies

35.1 Bronchiolitis Obliterans Syndrome Market In 2029 - Countries Offering Most New Opportunities

35.2 Bronchiolitis Obliterans Syndrome Market In 2029 - Segments Offering Most New Opportunities

35.3 Bronchiolitis Obliterans Syndrome Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Bronchiolitis Obliterans Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Bronchiolitis Obliterans Syndrome Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Bronchiolitis Obliterans Syndrome Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Bronchiolitis Obliterans Syndrome Market, Sub-Segmentation Of Lung Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Bronchiolitis Obliterans Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Bronchiolitis Obliterans Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Pfizer Inc. Financial Performance

Table 79: Boehringer Ingelheim Financial Performance

Table 80: University of California Health Financial Performance

Table 81: Texas Children’s Hospital Financial Performance

Table 82: Incyte Corporation Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Bronchiolitis Obliterans Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Bronchiolitis Obliterans Syndrome Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Bronchiolitis Obliterans Syndrome Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Bronchiolitis Obliterans Syndrome Market, Sub-Segmentation Of Lung Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Bronchiolitis Obliterans Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Bronchiolitis Obliterans Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Pfizer Inc. Financial Performance

Figure 79: Boehringer Ingelheim Financial Performance

Figure 80: University of California Health Financial Performance

Figure 81: Texas Children’s Hospital Financial Performance

Figure 82: Incyte Corporation Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Reversible Airway Diseases Treatment Global Market Report 2025 – By Treatment (Chest X Ray, Computed Tomography (CT) Scan, Lung Therapies, Surgery Transplant, Medications), By Diseases (Asthma, Chronic Bronchitis, Emphy...

Tracheitis Treatment Global Market Report 2025 – By Strain Type (Streptococcus Pneumoniae, Staphylococcus Aureus, Other Strains), By Indication (Tracheobronchitis, Bacterial Croup, Laryngotracheobronchitis), By Treatment...

Bronchoscope Global Market Report 2025 – By Type (Rigid Bronchoscopes, Flexible Bronchoscopes), By Usability (Reusable Bronchoscopes, Disposable Bronchoscopes), By Application (Diagnosis, Treatments), By End User (Hospit...

Bronchodilators Global Market Report 2025 – By Type (Beta-Adrenergic Bronchodilators, Anticholinergic Bronchodilators, Xanthine Derivatives, Other Types), By Route of Administration (Oral, Nasal (Inhalation), Injectable)...

Interstitial Lung Disease Global Market Report 2025 – By Drug Type (Oral Corticosteroids, Immune Suppressing, Anti-Fibrotic Medication, Other Drugs), By Disease Type (Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis...

Black Lung Disease Global Market Report 2025 – By Type (Simple Coal Worker’s Pneumoconiosis, Complicated Coal Worker’s Pneumoconiosis, Other Types), By Treatment (Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Ce...

Disposable Bronchoscope Global Market Report 2025 – By Product (Large, Regular, Slim, Ultra-slim, Extra-large), By Usage (Bedside Procedures, Emergency Rooms, Bronchoscopy Suites, Intensive Care Units (ICU)), By Indicati...

Frequently Asked Questions

What is the definition of the Bronchiolitis Obliterans Syndrome market?

How will the Bronchiolitis Obliterans Syndrome market drivers and restraints affect the market dynamics? What forces will shape the Bronchiolitis Obliterans Syndrome industry going forward?

The Bronchiolitis Obliterans Syndrome market major growth driver - The Growing Number Of Lung Transplantations Is Fueling The Growth Of The Market Due To The Rising Need To Treat Advanced Respiratory Conditions And Improve Patient Outcomes. For further insights on the Bronchiolitis Obliterans Syndrome market, request a sample here

What is the forecast market size or the forecast market value of the Bronchiolitis Obliterans Syndrome market?

The Bronchiolitis Obliterans Syndrome market size has grown strongly in recent years. The bronchiolitis obliterans syndrome market size has grown strongly in recent years. It will grow from $1.46 billion in 2024 to $1.59 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing incidence of post-transplant complications, rising awareness among healthcare professionals, growing utilization of immunosuppressive therapies, increasing research focus on rare pulmonary disorders, and growing adoption of advanced diagnostic imaging and lung function tests. The bronchiolitis obliterans syndrome market size is expected to see strong growth in the next few years. It will grow to $2.23 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing lung transplant procedures globally, a rising pipeline of targeted BOS therapies, growing government and private funding for orphan diseases, increasing collaborations and licensing agreements, and rising demand for personalized medicine and biomarkers. Major trends in the forecast period include advancements in inhaled drug delivery systems, integration of artificial intelligence in pulmonary diagnostics, technology-driven development of precision medicine, developments in bioinformatics and clinical trial analytics, and advancements in immunomodulatory therapies. For further insights on the Bronchiolitis Obliterans Syndrome market, request a sample here

How is the Bronchiolitis Obliterans Syndrome market segmented?

The bronchiolitis obliterans syndrome market covered in this report is segmented –
1) By Treatment Type: Medication, Oxygen Therapy, Lung Transplant
2) By Diagnosis: Pulmonary Function Tests, Imaging Tests, Lung Biopsy, Other Diagnosis
3) By Disease Type: Acute Bronchiolitis, Chronic Bronchiolitis Obliterans Syndrome
4) By End-User: Hospitals, Specialty Clinics, Diagnostic Centers, Other End-Users

Subsegments:
1) By Medication: Immunosuppressants, Corticosteroids, Antibiotics, Bronchodilators, Anti-Inflammatory Agents
2) By Oxygen Therapy: Continuous Oxygen Therapy, Intermittent Oxygen Therapy, Portable Oxygen Therapy, Hyperbaric Oxygen Therapy
3) By Lung Transplant: Single Lung Transplant, Double Lung Transplant, Living Donor Lung Transplant, Retransplantation For further insights on the Bronchiolitis Obliterans Syndrome market, request a sample here

Which region has the largest share of the Bronchiolitis Obliterans Syndrome market? What are the other regions covered in the report?

Who are the major players in the Bronchiolitis Obliterans Syndrome market?

What are the key trends in the Bronchiolitis Obliterans Syndrome market?

Major trends in the Bronchiolitis Obliterans Syndrome market include Advancements In At-Home Nebulized Therapies Accelerate Treatment For Bronchiolitis Obliterans Syndrome. For further insights on the Bronchiolitis Obliterans Syndrome market, request a sample here.